Navigation Links
Surgical technique in Spain enables extirpation of benign tumors of the pancreas
Date:2/3/2009

This release is available in Spanish.

This minimally invasive procedure, pioneering in Spain, has been developed by a team of surgeons at the University Hospital of Navarra, which brings together the greatest experience worldwide in this technique.

The results obtained in patients were recently published in the specialised surgery journal of greatest international impact, Annals of Surgery. It is the highest number of patients operated on using laparoscopic central pancreatectomy and that has been published in scientific literature worldwide. The specialists who took part in the study and who undertook the surgical technique are Doctors Fernando Pardo, Fernando Rotellar and Custodia Montiel, surgeons at the University Hospital of Navarra

As Doctor Pardo, Director of the Hepatobiliopancreatic Surgery service states, this technique has been recognised as a feasible procedure that reduces complications and hospitalisation periods, in a highly specific pancreatic pathology. The main achievement is having managed to devise a laparoscopic surgery technique for operations which to date has only been possible through open surgery. This new laparoscopic method is much less invasive and enables a large part of the gland to be conserved, and thus avoids the appearance of post-operative diabetes.

Complex technique - excellent results

The results of the laparoscopic central pancreatectomy have been excellent, according to Doctor Rotellar, and can even exceed those achieved by open surgery. According to this specialist, the laparoscopic technique reduces complications compared to open surgery. The period of hospitalisation is reduced from the average of ten days with the conventional procedure to four days with laparoscopy. The much lower rates for side effects also bear on reduced hospitalisation periods.

The tumours that these operations target are mainly neuroendocrine or cystic tumours of the pancreas that are benign or of low malignant potential. These lesions are diagnosed with greater frequency amongst young women, with an average age of 30, states Doctor Rotellar. Thus, the principal goal of this procedure is to obtain the optimum precision surgery in such a way that we are able to preserve the pancreas to the maximum. This is why laparoscopic central pancreatectomy is not suitable for tumours of poorer prognosis where it is paramount to operate radically in order to avoid a future regeneration of the tumour.

The importance of this surgical technique lies in managing to extirpate the minimum portion possible of the pancreas and, consequently, avoid the risk of the patient developing an intolerance to glucose or diabetes, besides any digestive problems that may arise from the lack of pancreatic enzymes, pointed out Doctor Pardo.

The surgeon also stated that laparoscopic central pancreatectomy is a pioneering technique, given its complex nature (after extirpating a portion of the pancreas, an anastomosis or union of the pancreatic duct with the intestine is carried out by laparoscopy). This joining to the intestine is necessary for the pancreas to be able to secrete its juices into it and, thus, it is a highly delicate operation.


'/>"/>

Contact: Oihane Lakar
oihane@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Pioneer Surgical Technology Hires Vice President of New Business Development
3. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
4. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
5. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
6. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
7. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
8. Study finds limiting work hours for surgical residents enhances training
9. STAAR Surgical Reports Operational Progress
10. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
11. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... , ... The producers of Enterprises TV are pleased to present ... world of instantaneous consumption proves very convenient for businesses. With new technologies constantly becoming ... which pollutes our air, water, and soil. It can also threaten the lives of ...
(Date:2/13/2016)... ... 13, 2016 , ... DDi , a Makro company, ... for its expertise in eClinical Solutions. DDi has built its solution competency with ... of global clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker ... Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and ... hydrated before the big event. The invitation-only gifting suite, held this year at the ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Fisher House ... Vegas Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy ... at the VA Southern Nevada Healthcare System. This will be the first Fisher ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016   National Community Pharmacists Association ... MBA issued the following statement today in response to ... the Centers for Medicare & Medicaid Services (CMS) ... beneficiary advocates and others: patient advocacy organizations ... still reviewing the full CMS analysis. Our initial reaction ...
(Date:2/12/2016)... , Feb. 12, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO ) is pleased to ... Account Management and Payor Strategies effective Jan. 23, 2016. ... ... ... Diplomat Specialty Pharmacy ...
(Date:2/12/2016)... MONTREAL , February 12, 2016 ... sofern nicht anders vermerkt)   ... Unternehmens http://www.telestatherapeutics.com abrufbar.    ... Website des Unternehmens http://www.telestatherapeutics.com ... Inc. (TSX:TST; PNK:BNHLF) veröffentlichte heute seinen Konzernabschluss ...
Breaking Medicine Technology: